Safety and efficacy of Bruton’s tyrosine kinase inhibitors in multiple sclerosis: A systematic review and network meta-analysis of randomized controlled trials Article Swipe

View

Abdallah Abbas , Haneen Sabet , Moaz Elsayed Abouelmagd , Mohamed El-Moslemani , Dalia Kamal Ewis , Saied M. Soliman , Mahmoud Tarek Hefnawy , Malak A. Hassan , Rana Ahmed Youssef , Hoda Awad , Mostafa Meshref , Ahmed Z. Obeidat ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1016/j.bnd.2025.06.003

Related Topics

Meta-Analysis

Randomized Controlled Trial

Concepts

Meta-analysis Randomized controlled trial Multiple sclerosis Medicine Tyrosine kinase Internal medicine Psychiatry Receptor

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.bnd.2025.06.003
OA Status: hybrid
References: 29
Related Works: 10
OpenAlex ID: https://openalex.org/W4413344700

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4413344700

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.bnd.2025.06.003

Digital Object Identifier
Title: Safety and efficacy of Bruton’s tyrosine kinase inhibitors in multiple sclerosis: A systematic review and network meta-analysis of randomized controlled trials

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-08-01

Full publication date if available
Authors: Abdallah Abbas, Haneen Sabet, Moaz Elsayed Abouelmagd, Mohamed El-Moslemani, Dalia Kamal Ewis, Saied M. Soliman, Mahmoud Tarek Hefnawy, Malak A. Hassan, Rana Ahmed Youssef, Hoda Awad, Mostafa Meshref, Ahmed Z. Obeidat

List of authors in order
Landing page: https://doi.org/10.1016/j.bnd.2025.06.003

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: hybrid

Open access status per OpenAlex
OA URL: https://doi.org/10.1016/j.bnd.2025.06.003

Direct OA link when available
Concepts: Meta-analysis, Randomized controlled trial, Multiple sclerosis, Medicine, Tyrosine kinase, Internal medicine, Psychiatry, Receptor

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
References (count): 29

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4413344700
doi	https://doi.org/10.1016/j.bnd.2025.06.003
ids.doi	https://doi.org/10.1016/j.bnd.2025.06.003
ids.openalex	https://openalex.org/W4413344700
fwci	0.0
type	article
title	Safety and efficacy of Bruton’s tyrosine kinase inhibitors in multiple sclerosis: A systematic review and network meta-analysis of randomized controlled trials
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11157
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9988999962806702
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2716
topics[0].subfield.display_name	Genetics
topics[0].display_name	Chronic Lymphocytic Leukemia Research
topics[1].id	https://openalex.org/T10137
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9945999979972839
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2734
topics[1].subfield.display_name	Pathology and Forensic Medicine
topics[1].display_name	Multiple Sclerosis Research Studies
topics[2].id	https://openalex.org/T11215
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9933000206947327
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2720
topics[2].subfield.display_name	Hematology
topics[2].display_name	Chronic Myeloid Leukemia Treatments
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C95190672
concepts[0].level	2
concepts[0].score	0.6487730145454407
concepts[0].wikidata	https://www.wikidata.org/wiki/Q815382
concepts[0].display_name	Meta-analysis
concepts[1].id	https://openalex.org/C168563851
concepts[1].level	2
concepts[1].score	0.6050159931182861
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1436668
concepts[1].display_name	Randomized controlled trial
concepts[2].id	https://openalex.org/C2780640218
concepts[2].level	2
concepts[2].score	0.5729290246963501
concepts[2].wikidata	https://www.wikidata.org/wiki/Q8277
concepts[2].display_name	Multiple sclerosis
concepts[3].id	https://openalex.org/C71924100
concepts[3].level	0
concepts[3].score	0.5504353046417236
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[3].display_name	Medicine
concepts[4].id	https://openalex.org/C42362537
concepts[4].level	3
concepts[4].score	0.4436952769756317
concepts[4].wikidata	https://www.wikidata.org/wiki/Q87099740
concepts[4].display_name	Tyrosine kinase
concepts[5].id	https://openalex.org/C126322002
concepts[5].level	1
concepts[5].score	0.33229029178619385
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[5].display_name	Internal medicine
concepts[6].id	https://openalex.org/C118552586
concepts[6].level	1
concepts[6].score	0.14821267127990723
concepts[6].wikidata	https://www.wikidata.org/wiki/Q7867
concepts[6].display_name	Psychiatry
concepts[7].id	https://openalex.org/C170493617
concepts[7].level	2
concepts[7].score	0.09899979829788208
concepts[7].wikidata	https://www.wikidata.org/wiki/Q208467
concepts[7].display_name	Receptor
keywords[0].id	https://openalex.org/keywords/meta-analysis
keywords[0].score	0.6487730145454407
keywords[0].display_name	Meta-analysis
keywords[1].id	https://openalex.org/keywords/randomized-controlled-trial
keywords[1].score	0.6050159931182861
keywords[1].display_name	Randomized controlled trial
keywords[2].id	https://openalex.org/keywords/multiple-sclerosis
keywords[2].score	0.5729290246963501
keywords[2].display_name	Multiple sclerosis
keywords[3].id	https://openalex.org/keywords/medicine
keywords[3].score	0.5504353046417236
keywords[3].display_name	Medicine
keywords[4].id	https://openalex.org/keywords/tyrosine-kinase
keywords[4].score	0.4436952769756317
keywords[4].display_name	Tyrosine kinase
keywords[5].id	https://openalex.org/keywords/internal-medicine
keywords[5].score	0.33229029178619385
keywords[5].display_name	Internal medicine
keywords[6].id	https://openalex.org/keywords/psychiatry
keywords[6].score	0.14821267127990723
keywords[6].display_name	Psychiatry
keywords[7].id	https://openalex.org/keywords/receptor
keywords[7].score	0.09899979829788208
keywords[7].display_name	Receptor
language	en
locations[0].id	doi:10.1016/j.bnd.2025.06.003
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S5407047429
locations[0].source.issn	3050-6239
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	3050-6239
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	Brain Network Disorders
locations[0].source.host_organization
locations[0].source.host_organization_name
locations[0].source.host_organization_lineage
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	Brain Network Disorders
locations[0].landing_page_url	https://doi.org/10.1016/j.bnd.2025.06.003
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5055542922
authorships[0].author.orcid	https://orcid.org/0000-0001-5101-5972
authorships[0].author.display_name	Abdallah Abbas
authorships[0].author_position	first
authorships[0].raw_author_name	Abdallah Abbas
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5099703706
authorships[1].author.orcid	https://orcid.org/0009-0001-9449-5707
authorships[1].author.display_name	Haneen Sabet
authorships[1].author_position	middle
authorships[1].raw_author_name	Haneen Sabet
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5113411884
authorships[2].author.orcid	https://orcid.org/0000-0002-0511-2429
authorships[2].author.display_name	Moaz Elsayed Abouelmagd
authorships[2].author_position	middle
authorships[2].raw_author_name	Moaz Elsayed Abouelmagd
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5093518764
authorships[3].author.orcid	https://orcid.org/0000-0002-5321-0867
authorships[3].author.display_name	Mohamed El-Moslemani
authorships[3].author_position	middle
authorships[3].raw_author_name	Mohamed El-Moslemani
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5093518765
authorships[4].author.orcid	https://orcid.org/0009-0008-4300-8113
authorships[4].author.display_name	Dalia Kamal Ewis
authorships[4].author_position	middle
authorships[4].raw_author_name	Dalia Kamal Ewis
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5029149793
authorships[5].author.orcid	https://orcid.org/0000-0001-8405-8370
authorships[5].author.display_name	Saied M. Soliman
authorships[5].author_position	middle
authorships[5].raw_author_name	Samar M. Soliman
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5032127735
authorships[6].author.orcid	https://orcid.org/0000-0002-7912-6399
authorships[6].author.display_name	Mahmoud Tarek Hefnawy
authorships[6].author_position	middle
authorships[6].raw_author_name	Mahmoud Tarek Hefnawy
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5108940116
authorships[7].author.orcid	https://orcid.org/0000-0002-1164-5002
authorships[7].author.display_name	Malak A. Hassan
authorships[7].author_position	middle
authorships[7].raw_author_name	Malak A. Hassan
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5111102192
authorships[8].author.orcid	https://orcid.org/0009-0006-8973-7659
authorships[8].author.display_name	Rana Ahmed Youssef
authorships[8].author_position	middle
authorships[8].raw_author_name	Rana Ahmed Youssef
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5111966292
authorships[9].author.orcid	https://orcid.org/0009-0004-4692-9461
authorships[9].author.display_name	Hoda Awad
authorships[9].author_position	middle
authorships[9].raw_author_name	Hoda Awad
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5074219534
authorships[10].author.orcid	https://orcid.org/0000-0003-0692-6309
authorships[10].author.display_name	Mostafa Meshref
authorships[10].author_position	middle
authorships[10].raw_author_name	Mostafa Meshref
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5004669262
authorships[11].author.orcid	https://orcid.org/0000-0002-3549-3277
authorships[11].author.display_name	Ahmed Z. Obeidat
authorships[11].author_position	last
authorships[11].raw_author_name	Ahmed Z. Obeidat
authorships[11].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1016/j.bnd.2025.06.003
open_access.oa_status	hybrid
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Safety and efficacy of Bruton’s tyrosine kinase inhibitors in multiple sclerosis: A systematic review and network meta-analysis of randomized controlled trials
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11157
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9988999962806702
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2716
primary_topic.subfield.display_name	Genetics
primary_topic.display_name	Chronic Lymphocytic Leukemia Research
related_works	https://openalex.org/W4242498609, https://openalex.org/W4385842477, https://openalex.org/W2775228109, https://openalex.org/W3176930657, https://openalex.org/W4406347553, https://openalex.org/W4394833138, https://openalex.org/W2139437222, https://openalex.org/W2355769538, https://openalex.org/W2770864300, https://openalex.org/W2055573962
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.1016/j.bnd.2025.06.003
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S5407047429
best_oa_location.source.issn	3050-6239
best_oa_location.source.type	journal
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l	3050-6239
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	Brain Network Disorders
best_oa_location.source.host_organization
best_oa_location.source.host_organization_name
best_oa_location.source.host_organization_lineage
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	Brain Network Disorders
best_oa_location.landing_page_url	https://doi.org/10.1016/j.bnd.2025.06.003
primary_location.id	doi:10.1016/j.bnd.2025.06.003
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S5407047429
primary_location.source.issn	3050-6239
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	3050-6239
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	Brain Network Disorders
primary_location.source.host_organization
primary_location.source.host_organization_name
primary_location.source.host_organization_lineage
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	Brain Network Disorders
primary_location.landing_page_url	https://doi.org/10.1016/j.bnd.2025.06.003
publication_date	2025-08-01
publication_year	2025
referenced_works	https://openalex.org/W3203730780, https://openalex.org/W3131957723, https://openalex.org/W2784859886, https://openalex.org/W4228997258, https://openalex.org/W2106804464, https://openalex.org/W3118509388, https://openalex.org/W4323313981, https://openalex.org/W4389878185, https://openalex.org/W4395072357, https://openalex.org/W1617328014, https://openalex.org/W2560438049, https://openalex.org/W6767567325, https://openalex.org/W4403513767, https://openalex.org/W2964015781, https://openalex.org/W4296489093, https://openalex.org/W4402630414, https://openalex.org/W3194931521, https://openalex.org/W4409247738, https://openalex.org/W2944582362, https://openalex.org/W3210611113, https://openalex.org/W2981743016, https://openalex.org/W3047313223, https://openalex.org/W2935804657, https://openalex.org/W3142731163, https://openalex.org/W2991597369, https://openalex.org/W3206241475, https://openalex.org/W4389866811, https://openalex.org/W4376595437, https://openalex.org/W2970684805
referenced_works_count	29
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	12
citation_normalized_percentile.value	0.48249872
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False